Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McDonnell

Showing results (271-280 of 374) with videos related to

Pageof 38
Sort By:
Endocrinology|May 27, 2010
The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasisCarolyn D DuSell, Erik R Nelson, Xiaojuan Wang, et al.
Molecular Therapy Oncolytics|December 23, 2021
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistanceJennifer L Green, Robin E Osterhout, Amy L Klova, et al.
Molecular Endocrinology (Baltimore, Md.)|March 5, 2002
Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transferR V Weatherman, C-Y Chang, N J Clegg, et al.
Molecular Endocrinology (Baltimore, Md.)|December 20, 2012
Androgens promote prostate cancer cell growth through induction of autophagyYan Shi, Jenny J Han, Jayantha B Tennakoon, et al.
The Journal of Chemical Physics|January 31, 2024
Reversible solvent interactions with UiO-67 metal-organic frameworksIsabella Goodenough, Mikaela C Boyanich, Ryan P McDonnell, et al.
Cancer Research|January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumorsS A Fuqua, S D Fitzgerald, D C Allred, et al.
Science (New York, N.Y.)|July 31, 1999
Peptide antagonists of the human estrogen receptorJ D Norris, L A Paige, D J Christensen, et al.
Nature Communications|April 28, 2018
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumorsGray R Anderson, Suzanne E Wardell, Merve Cakir, et al.
Oncogene|June 13, 2017
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signalingX Tang, C-K Ding, J Wu, et al.
Plos One|March 26, 2013
Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1Jung Eun Lee, Tomohito Gohda, William H Walker, et al.
Pageof 38

Showing results (271-280 of 374) with videos related to

Sort By:
Pageof 38
Endocrinology|May 27, 2010
The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasisCarolyn D DuSell, Erik R Nelson, Xiaojuan Wang, et al.
Molecular Therapy Oncolytics|December 23, 2021
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistanceJennifer L Green, Robin E Osterhout, Amy L Klova, et al.
Molecular Endocrinology (Baltimore, Md.)|March 5, 2002
Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transferR V Weatherman, C-Y Chang, N J Clegg, et al.
Molecular Endocrinology (Baltimore, Md.)|December 20, 2012
Androgens promote prostate cancer cell growth through induction of autophagyYan Shi, Jenny J Han, Jayantha B Tennakoon, et al.
The Journal of Chemical Physics|January 31, 2024
Reversible solvent interactions with UiO-67 metal-organic frameworksIsabella Goodenough, Mikaela C Boyanich, Ryan P McDonnell, et al.
Cancer Research|January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumorsS A Fuqua, S D Fitzgerald, D C Allred, et al.
Science (New York, N.Y.)|July 31, 1999
Peptide antagonists of the human estrogen receptorJ D Norris, L A Paige, D J Christensen, et al.
Nature Communications|April 28, 2018
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumorsGray R Anderson, Suzanne E Wardell, Merve Cakir, et al.
Oncogene|June 13, 2017
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signalingX Tang, C-K Ding, J Wu, et al.
Plos One|March 26, 2013
Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1Jung Eun Lee, Tomohito Gohda, William H Walker, et al.
Pageof 38